According to Greg Menke, Medical Decisions Network's CEO, "We've seen technology make sweeping improvements in the quality and cost of healthcare. Our MDN-CGS Computerized Insulin Dosing Software is another major contributor to these improvements because it gives hospital clinicians the power to control hyperglycemia, a huge and growing health and cost burden in this country."
The MDN CGS is a networked application, accessible from any computer on a hospital's network. This means that clinicians can continue a patient's infusion progress even when the patient is moved to a new unit.
"This FDA 510(k) clearance will be important for clinical administrators who are considering the move to this beneficial technology and feel more comfortable with FDA's nod," says Menke. "It's an important step for all of us."
For more information, visit http://www.mdnoutcomes.net.
About Medical Decisions Network
Medical Decisions Network (http://www.mdnoutcomes.net) is an affiliate of Medical Automation Systems, the leader in connectivity solutions for clinical laboratory point-of-care data management, and TEG, Virginia, LLC, an international healthcare research and consulting firm. MDN-CGS is a trademark of Medical Decisions Network.
1. Juneja, Rattan, et al, Utilization of a Computerized Intravenous Insulin Infusion Program to Control Blood Glucose in the Intensive Care Unit. Diabetes Technology & Therapeutics. Jun 2007, Vol. 9, No. 3: 232-240.
Contact: Rick Import
Office: (866) 791-6108 x 1017
E-mail: rimport@mdnoutcomes.net
| SOURCE Medical Decisions Network Copyright©2007 PR Newswire. All rights reserved |